Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04192149
Other study ID # 21331
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date February 19, 2019
Est. completion date February 20, 2021

Study information

Verified date December 2019
Source University of Virginia
Contact Sarah Adams
Phone 434-243-4239
Email neuromodlab@hscmail.mcc.virginia.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Focused ultrasound at low intensities is a form of neuromodulation with high spatial resolution that can be applied invasively or non-invasively using acoustic energy to affect neuronal activity. The purpose of this study is to better understand the effects of low intensity focused ultrasound (FUS) on the central nervous system. Specific patient populations within UVA health system are undergoing treatment that provide unique opportunities to study these effects.


Description:

Focused ultrasound (FUS) at low intensities is a form of neuromodulation with high spatial resolution that can be applied invasively or non-invasively using acoustic energy to affect neuronal activity. In this study the investigators intended to use specific patient populations to investigate the effects of FUS on different areas of the central nervous system (CNS). Each of our patients groups is undergoing a unique procedure at University of Virginia that will provide us different insights into the CNS. (1) Patients receiving an awake or asleep craniotomy for brain tumors and/or epilepsy will undergo a brain mapping procedure using electrical stimulation as a part of their normal care. The research procedures will duplicate this mapping with an invasive FUS mapping. (2) Patients undergoing long term monitoring for epilepsy will receive a non-invasive form of FUS stimulation which will be measured by their EEG cap and intracranial electrodes which are a part of their normal care. (3) Patients undergoing high intensity FUS treatment for tremor will be asked to wear a research provided EEG cap while undergoing a non-invasive low intensity FUS research procedure and changes in their tremor will be monitored. (4) Patients undergoing Deep Brain Stimulation (DBS) treatment for tremor will receive a non-invasive FUS stimulation observed through their newly implanted electrode. (5) Patients receiving a spinal surgery will undergo a spinal stimulation using electrical stimulation as a part of their normal care. The research procedures will duplicate this with an invasive FUS stimulation.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date February 20, 2021
Est. primary completion date February 20, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria:

- Be a patient receiving a treatment or surgical procedure specified below:

- Receiving a Craniotomy with brain mapping

- Receiving treatment or monitoring for Epilepsy

- Receiving either FUS or DBS treatment for Tremor

- Receiving a Spinal Surgery for stimulator placement

- Able to provide informed consent

- Must speak English

- Age 18-85

Exclusion Criteria:

- Not receiving one of the specified inclusion procedures

- Unable to provide consent

- Women who self-report pregnancy

- Patients who are currently incarcerated

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Focused Ultrasound
Low intensity focused ultrasound is sound energy stimulation at a low intensity of 1-30 W/cm2

Locations

Country Name City State
United States University of Virginia Charlottesville Virginia

Sponsors (1)

Lead Sponsor Collaborator
University of Virginia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Electrophysiological Changes as a result of Ultrasound Each participant group has different type of electrophysiological recording depending on the type of procedure. Recordings will include a baseline, during ultrasound, and/or post-ultrasound electrophysiology. baseline, immediately after ultrasound (same day, approximately 5-10 minutes after baseline)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05010226 - Focused Ultrasound for the Treatment of Pancreatic Cancer - an International Registry
Not yet recruiting NCT06391086 - Neuromodulation Effect of Focused Ultrasound for Motor Recovery in Patients With Stroke N/A
Recruiting NCT06292494 - Focused Ultrasound for Drug-resistant Epilepsy N/A